These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Useful markers for differential diagnosis of oncocytoma, chromophobe renal cell carcinoma and conventional renal cell carcinoma. Geramizadeh B; Ravanshad M; Rahsaz M Indian J Pathol Microbiol; 2008; 51(2):167-71. PubMed ID: 18603673 [TBL] [Abstract][Full Text] [Related]
4. [Value of special stains and immunohistochemistry in the diagnosis of renal epithelial neoplasms]. Dai L; Lü XH; Li ZH; Li R; Liu H; Liu YL; Hui YZ Zhonghua Bing Li Xue Za Zhi; 2004 Apr; 33(2):140-2. PubMed ID: 15132851 [TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical profile of common epithelial neoplasms arising in the kidney. Kim MK; Kim S Appl Immunohistochem Mol Morphol; 2002 Dec; 10(4):332-8. PubMed ID: 12613443 [TBL] [Abstract][Full Text] [Related]
6. DOG1, cyclin D1, CK7, CD117 and vimentin are useful immunohistochemical markers in distinguishing chromophobe renal cell carcinoma from clear cell renal cell carcinoma and renal oncocytoma. Zhao W; Tian B; Wu C; Peng Y; Wang H; Gu WL; Gao FH Pathol Res Pract; 2015 Apr; 211(4):303-7. PubMed ID: 25596994 [TBL] [Abstract][Full Text] [Related]
7. Profiling and classification tree applied to renal epithelial tumours. Allory Y; Bazille C; Vieillefond A; Molinié V; Cochand-Priollet B; Cussenot O; Callard P; Sibony M Histopathology; 2008 Jan; 52(2):158-66. PubMed ID: 18036175 [TBL] [Abstract][Full Text] [Related]
8. A panel of immunohistochemical stains assists in the distinction between ovarian and renal clear cell carcinoma. Cameron RI; Ashe P; O'Rourke DM; Foster H; McCluggage WG Int J Gynecol Pathol; 2003 Jul; 22(3):272-6. PubMed ID: 12819395 [TBL] [Abstract][Full Text] [Related]
9. Chromophobe renal cell carcinoma: a comparative study of histological, immunohistochemical and ultrastructural features using high throughput tissue microarray. Abrahams NA; MacLennan GT; Khoury JD; Ormsby AH; Tamboli P; Doglioni C; Schumacher B; Tickoo SK Histopathology; 2004 Dec; 45(6):593-602. PubMed ID: 15569050 [TBL] [Abstract][Full Text] [Related]
10. CD10+ and CK7/RON- immunophenotype distinguishes renal cell carcinoma, conventional type with eosinophilic morphology from its mimickers. Yasir S; Herrera L; Gomez-Fernandez C; Reis IM; Umar S; Leveillee R; Kava B; Jorda M Appl Immunohistochem Mol Morphol; 2012 Oct; 20(5):454-61. PubMed ID: 22417859 [TBL] [Abstract][Full Text] [Related]
11. [Diagnostic utility of immunohistochemistry in differential diagnosis of renal tumors with oncocytic features]. Zhang W; Yu WJ; Chen YQ; Kang EH; Liu Y; Zhuang J; Jiang YX; Chu J; Li YJ Zhonghua Bing Li Xue Za Zhi; 2016 Oct; 45(10):692-697. PubMed ID: 27760610 [No Abstract] [Full Text] [Related]
12. [Papillary renal cell carcinoma: clinico-pathologic studies of 33 cases]. Liu LN; Chen GY; Wang P; Zhang CH; Huang SF Zhonghua Zhong Liu Za Zhi; 2005 Feb; 27(2):102-5. PubMed ID: 15946550 [TBL] [Abstract][Full Text] [Related]
13. Cystic Renal Oncocytoma and Tubulocystic Renal Cell Carcinoma: Morphologic and Immunohistochemical Comparative Study. Skenderi F; Ulamec M; Vranic S; Bilalovic N; Peckova K; Rotterova P; Kokoskova B; Trpkov K; Vesela P; Hora M; Kalusova K; Sperga M; Perez Montiel D; Alvarado Cabrero I; Bulimbasic S; Branzovsky J; Michal M; Hes O Appl Immunohistochem Mol Morphol; 2016 Feb; 24(2):112-9. PubMed ID: 26180933 [TBL] [Abstract][Full Text] [Related]
14. Use of antibodies to RCC and CD10 in the differential diagnosis of renal neoplasms. Avery AK; Beckstead J; Renshaw AA; Corless CL Am J Surg Pathol; 2000 Feb; 24(2):203-10. PubMed ID: 10680888 [TBL] [Abstract][Full Text] [Related]
15. The diagnostic utility of MOC31, BerEP4, RCC marker and CD10 in the classification of renal cell carcinoma and renal oncocytoma: an immunohistochemical analysis of 328 cases. Pan CC; Chen PC; Ho DM Histopathology; 2004 Nov; 45(5):452-9. PubMed ID: 15500648 [TBL] [Abstract][Full Text] [Related]
16. [Expression of Ksp-cadherin in renal epithelial neoplasm and its clinicopathologic significance]. Rao Q; Zhou XJ; Shi QL; Yin HL; Ma HH; Zhou HB; Zhang RS Zhonghua Bing Li Xue Za Zhi; 2007 Jan; 36(1):15-8. PubMed ID: 17374232 [TBL] [Abstract][Full Text] [Related]
17. Diagnostic value of cytokeratin 7 and parvalbumin in differentiating chromophobe renal cell carcinoma from renal oncocytoma. Adley BP; Papavero V; Sugimura J; Teh BT; Yang XJ Anal Quant Cytol Histol; 2006 Aug; 28(4):228-36. PubMed ID: 16927643 [TBL] [Abstract][Full Text] [Related]
18. Distribution of cytokeratins and vimentin in adult renal neoplasms and normal renal tissue: potential utility of a cytokeratin antibody panel in the differential diagnosis of renal tumors. Skinnider BF; Folpe AL; Hennigar RA; Lim SD; Cohen C; Tamboli P; Young A; de Peralta-Venturina M; Amin MB Am J Surg Pathol; 2005 Jun; 29(6):747-54. PubMed ID: 15897741 [TBL] [Abstract][Full Text] [Related]
19. Cluster analysis of immunohistochemical profiles delineates CK7, vimentin, S100A1 and C-kit (CD117) as an optimal panel in the differential diagnosis of renal oncocytoma from its mimics. Carvalho JC; Wasco MJ; Kunju LP; Thomas DG; Shah RB Histopathology; 2011 Jan; 58(2):169-79. PubMed ID: 21323945 [TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical analysis of chromophobe renal cell carcinoma, renal oncocytoma, and clear cell carcinoma: an optimal and practical panel for differential diagnosis. Liu L; Qian J; Singh H; Meiers I; Zhou X; Bostwick DG Arch Pathol Lab Med; 2007 Aug; 131(8):1290-7. PubMed ID: 17683191 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]